glp-1 horror stories GLP1 Haemorrhoids Side Effects: Ozempic, Mounjaro The New York Times spotlighted

The more meaningful question is not: Do patients regain weight after stopping GLP-1s? It is: How should we transition patients from pharmacologic support to long-term weight maintenance? Obesity is a chronic disease

launch expected in early 2026 This approval expands treatment options and marks a major milestone for GLP-1 therapies

Data Synthesis Twenty-two reports and six prescribing sheets were included

The Trump Administration is delivering big news in Medicare

Amarasate comes from a specific variety of Hops grown in NZ a

Unlike many generic fat burners, this combines appetite control, metabolism support, and gut health in one formulation